Pulmonology News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–2 of 2 articles
Earlier
High impact NewsApr 29, 2026
Rein Therapeutics LTI-03 Phase 2 Trial Enrolls 8 Patients for Idiopathic Pulmonary Fibrosis Treatment
3 min
Dr. Priya NandakumarCritical impact NewsApr 29, 2026
AstraZeneca's BREZTRI Aerosphere Approved as First Triple Therapy for Asthma in Patients 12 and Older
2 min
Daniel BrooksExplore intelligence